PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-18.76%
Negative net income growth while AVGO stands at 21.13%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-1.67%
Negative yoy D&A while AVGO is 26.09%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
73.33%
Lower deferred tax growth vs. AVGO's 216.67%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
-7.04%
Negative yoy SBC while AVGO is 10.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
242.42%
Well above AVGO's 52.05% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
1160.00%
AR growth while AVGO is negative at -23.26%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
16.67%
Inventory shrinking or stable vs. AVGO's 95.00%, indicating lean supply management. David Dodd would confirm no demand shortfall.
176.47%
A yoy AP increase while AVGO is negative at -18.18%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-91.45%
Negative yoy usage while AVGO is 147.62%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-390.91%
Both negative yoy, with AVGO at -500.00%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
4.17%
Operating cash flow growth below 50% of AVGO's 54.74%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
13.71%
CapEx growth well above AVGO's 12.31%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-13.71%
Negative yoy acquisition while AVGO stands at 97.32%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
5.81%
Purchases growth of 5.81% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
0.15%
Liquidation growth of 0.15% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
35.54%
We have some outflow growth while AVGO is negative at -155.56%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
41.98%
Lower net investing outflow yoy vs. AVGO's 87.67%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
No Data
No Data available this quarter, please select a different quarter.
-51.86%
Negative yoy issuance while AVGO is 28.13%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.